Lex Aurum Advisors, LLC X4 Pharmaceuticals, Inc Transaction History
Lex Aurum Advisors, LLC
- $430 Million
- Q3 2024
A detailed history of Lex Aurum Advisors, LLC transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Lex Aurum Advisors, LLC holds 16,000 shares of XFOR stock, worth $8,960. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,000
Previous 16,000
-0.0%
Holding current value
$8,960
Previous $9,000
11.11%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding XFOR
# of Institutions
103Shares Held
99.9MCall Options Held
213KPut Options Held
50.6K-
Bain Capital Life Sciences Investors, LLC Boston, MA16.9MShares$9.47 Million2.03% of portfolio
-
Nea Management Company, LLC Timonium, MD15MShares$8.39 Million0.77% of portfolio
-
Black Rock Inc. New York, NY10.7MShares$5.98 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.44MShares$4.73 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.13MShares$3.99 Million0.11% of portfolio
About X4 Pharmaceuticals, Inc
- Ticker XFOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,646,096
- Market Cap $38.4M
- Description
- X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...